J0572 – Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine

Long description

Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine

Short description

Bupren/nal up to 3mg bupreno

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

D Special coverage instructions apply

BETOS category

O1E Other drugs

Added

January 1, 2015

Last change

January 1, 2016 – No change

Nearby J codes

• J0525 – Injection, cefotetan disodium, 10 mg
• J0528 – Injection, fosfomycin disodium, 20 mg
• J0558 – Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
• J0561 – Injection, penicillin g benzathine, 100,000 units
• J0565 – Injection, bezlotoxumab, 10 mg
• J0567 – Injection, cerliponase alfa, 1 mg
• J0570 – Buprenorphine implant, 74.2 mg
• J0571 – Buprenorphine, oral, 1 mg
• J0573 – Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
• J0574 – Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
• J0575 – Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
• J0576 – Injection, buprenorphine extended-release (brixadi), 1 mg
• J0577 – Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
• J0578 – Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
• J0582 – Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg
• J0583 – Injection, bivalirudin, 1 mg